Detalhe da pesquisa
1.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882781
2.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597472
3.
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
Target Oncol
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570422
4.
Role of Underlying Liver Pathology in the Development of Immune-Related Hepatitis: A Case-Control Study.
Target Oncol
; 18(4): 601-610, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358780
5.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(2): 286-294, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481176
6.
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328287
7.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
; 21(5): 584-593, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414620
8.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36155169
9.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
; 20(2): 165-175, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078711
10.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778337
11.
Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report.
BMC Med Genomics
; 14(1): 137, 2021 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022887